Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

896 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.
Echazú A, Juarez M, Vargas PA, Cajal SP, Cimino RO, Heredia V, Caropresi S, Paredes G, Arias LM, Abril M, Gold S, Lammie P, Krolewiecki AJ. Echazú A, et al. Among authors: gold s. PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0006003. doi: 10.1371/journal.pntd.0006003. eCollection 2017 Oct. PLoS Negl Trop Dis. 2017. PMID: 28991899 Free PMC article.
Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model.
Errecalde J, Lifschitz A, Vecchioli G, Ceballos L, Errecalde F, Ballent M, Marín G, Daniele M, Turic E, Spitzer E, Toneguzzo F, Gold S, Krolewiecki A, Alvarez L, Lanusse C. Errecalde J, et al. Among authors: gold s. J Pharm Sci. 2021 Jun;110(6):2501-2507. doi: 10.1016/j.xphs.2021.01.017. Epub 2021 Jan 23. J Pharm Sci. 2021. PMID: 33493479 Free PMC article.
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial.
Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, Álvarez L, Fleitas PE, Ceballos L, Golemba M, Fernández F, Fernández de Oliveira D, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C. Krolewiecki A, et al. Among authors: gold s. EClinicalMedicine. 2021 Jun 18;37:100959. doi: 10.1016/j.eclinm.2021.100959. eCollection 2021 Jul. EClinicalMedicine. 2021. PMID: 34189446 Free PMC article.
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]".
Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, Álvarez L, Fleitas PE, Ceballos L, Golemba M, Fernández F, de Oliveira DF, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C. Krolewiecki A, et al. Among authors: gold s. EClinicalMedicine. 2021 Sep;39:101119. doi: 10.1016/j.eclinm.2021.101119. Epub 2021 Aug 26. EClinicalMedicine. 2021. PMID: 34462733 Free PMC article.
Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers.
Algorta J, Krolewiecki A, Pinto F, Gold S, Muñoz J. Algorta J, et al. Among authors: gold s. Front Pharmacol. 2022 Jul 14;13:914886. doi: 10.3389/fphar.2022.914886. eCollection 2022. Front Pharmacol. 2022. PMID: 35910353 Free PMC article.
The BENEFIT Trial: Where Do We Go from Here?
Pecoul B, Batista C, Stobbaerts E, Ribeiro I, Vilasanjuan R, Gascon J, Pinazo MJ, Moriana S, Gold S, Pereiro A, Navarro M, Torrico F, Bottazzi ME, Hotez PJ. Pecoul B, et al. Among authors: gold s. PLoS Negl Trop Dis. 2016 Feb 25;10(2):e0004343. doi: 10.1371/journal.pntd.0004343. eCollection 2016 Feb. PLoS Negl Trop Dis. 2016. PMID: 26913759 Free PMC article. No abstract available.
A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.
The Ivermectin Roadmappers; Billingsley P, Binka F, Chaccour C, Foy B, Gold S, Gonzalez-Silva M, Jacobson J, Jagoe G, Jones C, Kachur P, Kobylinski K, Last A, Lavery JV, Mabey D, Mboera D, Mbogo C, Mendez-Lopez A, Rabinovich NR, Rees S, Richards F, Rist C, Rockwood J, Ruiz-Castillo P, Sattabongkot J, Saute F, Slater H, Steer A, Xia K, Zullinger R. The Ivermectin Roadmappers, et al. Among authors: gold s. Am J Trop Med Hyg. 2020 Feb;102(2s):3-24. doi: 10.4269/ajtmh.19-0620. Am J Trop Med Hyg. 2020. PMID: 31971144 Free PMC article.
NGcGM3 ganglioside: a privileged target for cancer vaccines.
Fernandez LE, Gabri MR, Guthmann MD, Gomez RE, Gold S, Fainboim L, Gomez DE, Alonso DF. Fernandez LE, et al. Among authors: gold s. Clin Dev Immunol. 2010;2010:814397. doi: 10.1155/2010/814397. Epub 2010 Oct 27. Clin Dev Immunol. 2010. PMID: 21048926 Free PMC article. Review.
896 results